Characterization of astroglial versus oligodendroglial phenotypes in glioblastomas by means of quantitative morphonuclear variables generated by computer-assisted microscopy

被引:23
作者
Decaestecker, C
Camby, I
Gordower, L
Dewitte, O
Cras, P
Martin, JJ
Pasteels, JL
Van Ham, P
Brotchi, J
Kiss, R
Salmon, I
机构
[1] Free Univ Brussels, Fac Med, Histol Lab, B-1070 Brussels, Belgium
[2] Free Univ Brussels, Erasme Hosp, Dept Neurosurg, Brussels, Belgium
[3] Free Univ Brussels, Erasmus Hosp, Dept Pathol, Brussels, Belgium
[4] Free Univ Brussels, Fac Sci Appl, Dept Digital & Log Syst, Brussels, Belgium
[5] Univ Antwerp, Dept Neuropathol, B-2020 Antwerp, Belgium
关键词
cell lineage; Feulgen staining; gliomas; image cytometry; phenotype;
D O I
10.1097/00005072-199808000-00008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The current WHO classification places glioblastomas in the astrocytoma category. However, whether or not glioblastomas also show oligodendroglial differentiation remains a matter of controversy. This study investigates, at the morphonuclear level, the hypothesis that some glioblastomas (GBMs) may also represent the ultimate level of malignancy in the oligodendroglial lineage. Using a series of 164 GBMs, we sought to ascertain whether any of these GBMs exhibited phenotypical characteristics that were more closely related to oligodendroglial lineages than astrocytic lineages. Phenotypical features were quantitatively determined by means of the computer-assisted microscope analysis of Feulgen-stained nuclei, a process that made it possible to quantitatively describe the]patterns of the cell nuclei (and, more specifically, of their chromatin) through 16 variables, and the distribution of the nuclear DNA content (DNA ploidy) through 8 variables. The phenotypical characteristics typical of astrocytic and oligodendroglial tumors were analyzed by means of Discriminant Analysis, a statistical multivariate analysis, performed on a series of 65 astrocytic and oligodendroglial tumors. This series consisted of 14 WHO grade II and 19 grade III astrocytomas and 24 WHO grade II and 8 grade :[II oligodendrogliomas. This multivariate analysis enabled an accurate model to be produced that distinguished between astrocytomas and oligodendrogliomas on the basis of 5 cytometry-generated variables. This model was used to characterize the phenotype of each of the 164 glioblastomas. The results show that of these 164 glioblastomas, 6 (about 3.5%) displayed phenotypes that were very similar to oligodendrogliomas, and 141 displayed phenotypes that were very similar to astrocytomas. The phenotypes of the 17 remaining GBMs were too ambiguous to be categorized as having a pure astrocytic or oligodendroglial lineage.
引用
收藏
页码:791 / 802
页数:12
相关论文
共 39 条
[1]  
BURGER PC, 1994, TUMORS CENTRAL NERVO, P452
[2]   SUCCESSFUL CHEMOTHERAPY FOR RECURRENT MALIGNANT OLIGODENDROGLIOMA [J].
CAIRNCROSS, JG ;
MACDONALD, DR .
ANNALS OF NEUROLOGY, 1988, 23 (04) :360-364
[3]   LONG-TERM SURVIVAL IN PATIENTS WITH GLIOBLASTOMA-MULTIFORME [J].
CHANDLER, KL ;
PRADOS, MD ;
MALEC, M ;
WILSON, CB ;
SALEMAN, M ;
BLACK, PM .
NEUROSURGERY, 1993, 32 (05) :716-720
[4]   GENE AND CHROMOSOMAL ALTERATIONS ASSOCIATED WITH THE DEVELOPMENT OF HUMAN GLIOMAS [J].
COLLINS, VP ;
JAMES, CD .
FASEB JOURNAL, 1993, 7 (10) :926-930
[5]   GENE AMPLIFICATION IN HUMAN GLIOMAS [J].
COLLINS, VP .
GLIA, 1995, 15 (03) :289-296
[6]  
COONS SW, 1993, CANCER, V72, P3052, DOI 10.1002/1097-0142(19931115)72:10<3052::AID-CNCR2820721030>3.0.CO
[7]  
2-7
[8]   REGIONAL HETEROGENEITY IN THE PROLIFERATIVE ACTIVITY OF HUMAN GLIOMAS AS MEASURED BY THE KI-67 LABELING INDEX [J].
COONS, SW ;
JOHNSON, PC .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1993, 52 (06) :609-618
[9]   Nearest-neighbor classification for identification of aggressive versus nonaggressive low-grade astrocytic tumors by means of image cytometry-generated variables [J].
Decaestecker, C ;
Salmon, I ;
Dewitte, O ;
Camby, I ;
VanHam, P ;
Pasteels, JL ;
Brotchi, J ;
Kiss, R .
JOURNAL OF NEUROSURGERY, 1997, 86 (03) :532-537
[10]  
Decaestecker C, 1996, J PATHOL, V178, P274, DOI 10.1002/(SICI)1096-9896(199603)178:3<274::AID-PATH478>3.0.CO